Percutaneous transhepatic biliary drainage (PTBD) has been widely used, but it has a potential risk of tumor spread along the catheter tract. We herein present a case of solitary PTBD tract metastasis after curative resection of perihilar cholangiocarcinoma. Initially, endoscopic nasobiliary drainage was done on a 65 year-old female patient, but the cholangitis did not resolve. Thus a PTBD catheter was inserted into the right posterior duct. Right portal vein embolization was also performed. Curative surgery including right hepatectomy and bile duct resection was performed 16 days after PTBD. After 12 months, serum CA19-9 had increased gradually without any symptoms. Finally, a small right pleural metastasis was found through strict tumor surveillance for 6 months. Chemoradiation therapy was performed, but there was no response to treatment. As the tumor progressed, she complained of severe dyspnea and finally died from tumor dissemination to the chest and bones 18 months after the first detection of PTBD tract recurrence and 36 months after surgery. No intra-abdominal recurrence was found until the terminal stage. This PTBD tract recurrence was attributed to the PTBD even though it was in place for only 16 days. Although such recurrence is rare, its risk should be taken into account during follow-up of patients who have received PTBD before. 
INTRODUCTION
Biliary obstruction from malignancy of the hepatobiliary system requires biliary drainage through a percutaneous or endoscopic approach. Percutaneous transhepatic biliary drainage (PTBD) has been widely used for a long time, but recently endoscopic biliary drainage has been preferred as a primary method because of various disadvantages of PTBD such as procedure-related complications and tumor spread along the PTBD tract. [1] [2] [3] Endoscopic nasobiliary biliary drainage (ENBD) or endoscopic retrograde biliary drainage is effective for biliary decompression of the distal cholangiocarcinoma. Thus PTBD is only occasionally necessary. However, in perihilar cholangiocarcinoma, endoscopic biliary drainage is often not feasible or effective due to complexity of the biliary obstruction patterns. Thus, PTBD is still frequently performed for perihilar cholangiocarcinoma, with concomitant use of ENBD. Although the Nagoya University group reported a 5.6% incidence of PTBD tract recurrence after resection of perihilar cholangiocarcinoma, 1 the actual incidence of PTBD tract recurrence does not appear to be so high. We herein present a unique case of solitary catheter tract metastasis associated with PTBD after resection of perihilar cholangiocarcinoma.
CASE
The patient was a 65 year-old female who gave us the impression that she had perihilar cholangiocarcinoma and a sudden onset of obstructive jaundice. Initial endoscopic retrograde cholangiography (ERC) showed multifocal nar- Since the endoscopic nasobiliary biliary drainage was not sufficient for biliary decompression of the right lobe, a percutaneous transhepatic biliary drainage catheter was inserted. showing increased metabolic activity of the right lateral chest wall (Fig. 3) . Chest CT showed a small subpleural nodule in the right chest, implicating a benign nodule such as inflammatory granuloma. However, after matching with PET findings, this subpleural nodule was highly suspected of PTBD tract metastasis. At this time, she was completely free of any symptom (Fig. 4) .
Worrying about the subsequent occurrence of another intra-abdominal recurrence, we decided to perform palliative chemoradiation therapy instead of radical resection of the involved chest wall. Even after the second chemoradiation therapy, serum CA19-9 had gradually increased, implying that there was no treatment response. 
DISCUSSION
PTBD tract tumor recurrence after resection of perihilar cholangiocarcinoma is uncommon, but the reported incidence from the Nagoya University group was much higher than expected. 1 In fact, it is not possible to estimate its actual incidence because their report is only one collective review from a large-volume center and others have presented sporadic cases so far. 1, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] According to our institutional experience, 4,5 its incidence is around 2%.
However, after looking into the details of the Nagoya University experience, we found that it included several non-negligible risk points specific to that institution, including presence of synchronous metastasis at the time of surgery, high incidence of multiple PTBD catheters and prolonged stay of PTBD catheters. 1 They reported that the independent risk factors for PTBD tract recurrence were multiple catheters, duration of PTBD over 60 days and papillary tumor growth. Considering that recently a single PTBD with or without ENBD for a few weeks has often been used for biliary decompression for patients with perihilar cholangiocarcinoma, the actual risk of tumor metastasis associated with PTBD may be lower than previously
reported.
The present case appears to be very unusual because of the absence of intra-abdominal recurrence. In fact, most PTBD tract recurrences were followed by subsequent intra-abdominal recurrence, inducing multiple tumor recurrences that led to shortened survival. Therefore, locore- In conclusion, we present a case of unique solitary tumor recurrence at the PTBD tract, in which the PTBD catheter was kept for only 16 days. Although such a recurrence is rare, its risk should be taken into account during follow-up of patients who had received PTBD before.
